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SUMMARY
Introduction: Type 2 diabetes (DM 2) is one of the first ten causes of mortality in Colombia. Pre-diabetes is a state of
hyperglycemia that associated with other risk factors appears 5-10 years before this disease. It has been reported that
controlling the diet and exercise decreases the probability of suffering DM 2 by 60%. This intervention requires establishing
the risk in pre-diabetic patients.
Objectives: To detect patients with pre-diabetes who are members of a private health care provider (EPS for its name in
Spanish) in Cali and to describe the clinical and epidemiological characteristics related to the risk of developing DM 2.
Materials and methods: This is a cross-sectional descriptive study in patients with altered glucemias (Impaired fasting
glucose: 100-125 mg/dl and impaired glucose tolerance: 140-199 mg/dl). Clinical histories were reviewed and surveys on risk
factors, habits and perception of knowledge were conducted. We determined: fasting glucose, vital signs, and anthropometric
measures.
Results: 111 patients were included (64% women) whose most common occupation was home duties (39.6%). The
descriptive analysis reported high risk; the results were: noticeable presence of associate pathological antecedents as follows:
Diabetes in the family (64%), obesity (54.1%), dyslipidemia (72.1%), and hypertension (66.7%) in a population with a mean
age at 51 years and 10.8% were under 40 years of age. This great proportion of overweight or obesity (86.5%), according to
BMI, influenced the determination of the high cardio-metabolic risk (81%, agreeing with the WHO). When evaluating diet
with consumption frequency, we still found the intake of simple carbohydrates and animal fats; when reviewing physical
activity,  53.2% of the patients reported activity in the last 7 days according to the International Physical Activity Questionnaire
(IPAQ).
Conclusions: 66% of pre-diabetics did not have diagnosis of some disorder of the metabolism of carbohydrates. More
than 70% of the patients have high risk of DM 2 with pathological antecedents, inadequate health habits, and low perception
of disease complications.
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RESUMEN
Introducción: La diabetes tipo 2 (DM 2) es una de las diez primeras causas de mortalidad en Colombia. La prediabetes
es un estado de hiperglucemia que, asociado con otros factores de riesgo, se presenta 5-10 años antes de dicha enfermedad.
Se ha informado que controlar la dieta y el ejercicio disminuye la probabilidad de padecer DM 2 hasta en 60%. Identificar
y caracterizar el riesgo en los pacientes prediabéticos contribuye en la prevención de la DM 2.
Objetivos: Detectar los pacientes con prediabetes afiliados a una EPS privada de Cali, evaluar y describir su estado de
riesgo.
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Materiales y métodos: Se realizó estudio descriptivo
transversal en pacientes con glucemias alteradas (glucemia
en ayunas, 100-125 mg/dl y glucemia post-carga, 140-199
mg/dl). Se revisaron historias clínicas y se realizó encuesta
de factores de riesgo, hábitos y percepción de conocimientos.
Se determinaron glucemia en ayunas, signos vitales y medi-
das antropométricas.
Resultados: Se incluyeron 111 pacientes (64% mujeres),
con edad promedio de 51 años y 10.8% menor de 40 años,
cuya mayor ocupación fue el hogar (39.6%). Se encontró alto
riesgo para desarrollar DM 2 de acuerdo con los siguientes
resultados: alta proporción de antecedentes patológicos aso-
ciados como diabetes familiar (64%), obesidad (54.1%),
dislipidemias (72.1%) e hipertensión (66.7%). La gran pro-
porción de sobrepeso u obesidad según IMC hallado (86.5%),
influyó en la determinación del alto riesgo cardiometabólico
(81% según criterios de la OMS). Al evaluar dieta con
frecuencia de consumo, se encontró todavía ingesta de
carbohidratos simples y grasas animales; luego de revisar
actividad física, 53.2% informó actividad en la semana antes
del Cuestionario Internacional de Actividad Física (IPAQ).
Conclusiones: Del total de los prediabéticos, 66% no
tenía diagnóstico de algún desorden del metabolismo de los
carbohidratos. Más del 70% de los pacientes tiene alto riesgo
de DM 2 con hábitos saludables inadecuados y baja percep-
ción de las complicaciones.
Palabras clave: Estado prediabético;
Intolerancia a la glucosa; Diabetes tipo II;
Prevención primaria; Síndrome X metabólico.
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To understand the natural history of DM 2, allowing
to identify patients with prediabetes1 who are at risk of
developing this disease. Initially, there is resistance to
insulin, which produces decreased peripheral
consumption of glucose, leading to increased levels of
glucose, which during this stage can be between 100-
125 mg/dl. This state is known as Impaired Fasting
Glucose (IFG). As compensation to resistance, the
pancreas increases insulin release and, in a long term a
dysfunction of beta cell occurs and decrease the
pancreatic secretion. This state is known as Impaired
Glucose Tolerance2 (IGT) and refers to glucose values
between 140-199 mg/dl, two hours after an oral load of
75 g of glucose in the glucose tolerance test. A patient
with pre-diabetes can present these two states or any of
them in association with any or some of the following
risk factors: obesity/overweight condition, sedentary
life style, dyslipidemia, genetic predisposition, hyper-
tension, cigarette smoking, inadequate diet, associated
pathologies, age, and ethnicity. These states are part of
a prior stage to the development of DM 2, which can last
between five and ten years. Once the DM 2 is instituted,
there is reduction and irreversible damage of the beta
cells3 that diminish insulin secretion in contrast to
prediabetic state in which the changes in secretion of
the pancreas can be reversed. It is important to remark
that to a major state of hyperglycemia increase the risk
of micro and macrovascular damage associated with
endothelial dysfunction, constituting a risk factor for
developing cardiovascular disease4.
Diabetes mellitus (DM) is defined according to the
World Health Organization (WHO) as a metabolic
disease and is classified etiologically into type one and
type two5. The hyperglycemia of DM is mainly due to
resistance and to abnormalities in insulin production6.
In the long term, it affects micro- and macro-circulation,
generating damage in the renal, nervous, and coronary
functions.
Currently, DM is an important public health problem
because of its high morbidity and mortality, increased
health care costs, and decreased quality of life for
patients affected for it. The International Diabetes
Federation conducts theoretical estimations of the
prevalence of DM based on worldwide epidemiological
data. In urban regions for 2010, a worldwide prevalence
of 6.4% for diabetes and 7.8% for impaired tolerance to
glucose7 (pre-diabetes) was estimated, which could rise
to 7.7% and 8.4%, respectively, by 2030. In Colombia
for 2010, DM prevalence was calculated at 4.8%,
which could rise to 6.2% by 2030. In the mortality
analysis for 2005 in Cali, published by Center for the
Development and Evaluation of Politics and Tecnology
in Public Health (CEDETES for its name in spanish),
DM places 12th with a death rate of 19.1 per 100-
thousand inhabitants8.
According to world statistics, DM 2 represents
approximately 90% of the DM cases; its prevalence
increases with age and over 65 years of age it is
accompanied by great co-morbidity7. It is characterized
by the partial lack of insulin, slow progression, and
genetic association7 of 90% of the cases.
Prevention of DM 2 is a Public Health priority. In
this sense, Latin American Diabetes Association9
established that, regarding primary prevention infor-
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mation must be disclosed  to avoiding the development
of this disease in high-risk individuals, encouraging
them to modify their risk factors. Multiple studies
where there has been early intervention with exercise
programs for individuals at high risk of developing DM
2 have revealed greater decrease in the incidence of this
disease (58%) than pharmacological intervention with
metformin, given that in this case the decrease only
reaches 31%10.
Pre-diabetic patients are in the age range between 20
and 79 years; most are asymptomatic and in some cases
are incidentally detected when they have a blood sugar
test prior to surgery or during a general check up11.
Hence, it is important to design public health strategies
for early detection of these patients to permit opportune
intervention.
This study seeks to determine the socio-demographic
characteristics, life style, and risk factors for developing
DM 2 and cardiovascular disease in patients with pre-
diabetes. The purpose of this study is to contribute in
the development of primary prevention strategies, which
permit early identification of individuals with DM 2
risk, so they could be part of intervention and education
programs that guide pre-diabetic patients to adopting
healthy life styles.
MATERIALS AND METHODS
An observational, descriptive, cross-sectional study
was designed; patients were selected under 65 years of
age, because above this age greater prevalence of dia-
betes than pre-diabetes has been reported in literature,
along with high association of other co-morbidities.
These patients were affiliated to a private Health Care
Service Provider (EPS for its name in Spanish) of the
contributive General System of Health Social Security
(SGSSS for its name in Spanish) in the city of Cali.
After reviewing the data base at the EPS laboratory
regarding altered blood glucose results (fasting glucose
between 100-125 mg/dl, and glucose tolerance test
between 140-199 mg/dl), taken between 01 January
and 31 August of 2008, 6659 results of altered blood
glucose were found in total, of which 5857 were results
of Fasting glucose and 802 of glucose tolerance tests
within the values mentioned. After organizing the results
per patient and determining how many of them presented
both tests altered, 406 patients were found whose
clinical history was reviewed. We excluded patients
previously diagnosed with DM, those with no clinical
history, or those who decided not to participate in the
study. In the end, there were 139 patients who were
called and accepted to be part of the investigation; when
subjected to the fasting glucose test, 28 patients presented
alteration for this test and were excluded because they
completed the criteria for the diagnosis for DM 2,
leaving 111 pre-diabetic patients. With this number of
patients, we obtained primary and secondary information
on the DM 2 risk factors, through a guided survey and
review of the clinical history, respectively.
From the clinical history we recorded on a written
format information regarding the pathological
antecedents (diseases associated to hyperglycemia and
hyperinsulinemia), the pharmacological antecedents
(medications consumed during the last year), and the
results of the laboratory tests (glycemia and lipid profile).
Through the guided survey, we gathered information
about socio-demographic characteristics (gender, age,
socio-economic level, ethnicity, and marital status)¸
updated personal and family pathological antecedents
(diseases associated to hyperglycemia and hyper-
insulinemia), and asked about habits (cigarette and
alcohol consumption) and about healthy life styles. The
information about physical activity and diet was recorded
by using the International Physical Activity Question-
naire (IPAQ), validated in Argentina12 and the
questionnaire of the frequency of food intake during 24
hours, respectively. With the information obtained
through the IPAQ each subject was classified as very
active, active, insufficiently active, or sedentary,
considering the intensity, duration, and frequency of
the physical activity during the last week, and the
following classification scheme12 (Table 1).
The guided survey also inquired about the perception
about DM 2 and pre-diabetes; questions were made
regarding the pre-diabetes diagnosis, the risk factors,
diseases associated with DM 2, the complications of
DM 2, glycemia control and healthy life styles. After
collecting this information from the 111 patients, we
proceeded to taking anthropometric measurements.
These were determined in the following manner: weight
(kg) with Health Scale Meter® with one decimal value14.
Height was determined with a altimeter 1. With height
and weight measurements the Body Mass Index (BMI)
was calculated. Waist circumference was measured
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with a Lufkin measuring tape 0.5 cm wide, two to three
meters long and 0.1 cm of resolution, using the technique
of the tape juxtaposed on the abdominal zone at an
intermediate height between the last rib and the iliac
crest. Normal values were considered13 for women <80
cm and for men <90 cm. Blood pressure was taken with
the ausculatory method and using a Littman Master
Classic Stethoscope and a Wellch Allyn Tensiometer.
A reference value14 for Blood Pressure <130/85 was
considered.
After 12 h of fasting, a blood simple was taken via
venipuncture on the antecubital vein; the blood was
collected in vaccutainer tubes without anticoagulant
and immediately stored at 4°C and separated from the
serum through centrifuge at 3000 rpm/15 min; thereafter,
it was stored at -20ºC, to then measure glucose in mg/
dl and, thus, update the value of fasting glucose and
evaluate the patients that would be excluded because
they fulfilled the criteria for the DM 2 diagnosis.
The results were analyzed in Epi-Info CDC 3.5.1
(2008). Proportions were used to analyze qualitative
variables and central tendency measurements for
quantitative variables, assuming a 5% of error (p<0.05).
The Z test was used to evaluate the difference between
proportions.
This study was approved by the Ethics Committee at
Universidad del Valle and the Research Committee at
the EPS. The informed consent form was read and
explained to each patient; once understood and accepted,
111 patients signed it prior to starting the survey. The
results were given to the patients within the framework
of an educational conference on pre-diabetes and
prevention of DM 2. Results compatible with DM 2
diagnosis were reported to the EPS.
RESULTS
The risk factors evaluated in these patients are
presented in the following categories, which were
previously described:
Regarding the socio-demographic characteristics,
we found that most of the cases studied were women
(64%), the mean age was 51 years ± 10.9, with 89.2%
between 40-65 years of age and 10.8 % below 40 years
of age. A total of 86.5% were classified as mestizo
(Table 2 summarizes other characteristics).
Table 1
IPAQ classification of the level of activity
Sedentary. Did not engage in physical activity for at least 10 continuous minutes during the week.
Insufficiently active. Engages in physical activity for at least 10 minutes per week, but insufficient to be
classified as active. May be divided into two groups:
  A. Reaches at least one of the recommended criteria
     a. Frequency: 5 days/week or
     b. Duration: 150 min/week
  B. Did not reach any of the recommendation criteria
Observation: To conduct this classification, add the frequency and the duration of the different types of activity
(Walking + Moderate + Vigorous)
Active. Complied with the recommendations:
  a. Vigorous: >3 days/week and >20 min per session
  b. Moderate or walking: >5 days/week and >30 min per session
  c. Any activity added: >5 days/week and >150 min/week (Walking + Moderate + Vigorous)
Very active. Complied with the recommendations and:
  a. Vigorous: >5 days/week and >30 min per session or
  b. Vigorous: >3 days/week and >20 min per session + moderate and/or walking : >5 days/week
      and >30 min per session
International Physical Activity Surveillance (IPAS, TANGO); Buenos Aires, Argentina, 2003
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Findings on patient pathological antecedents were:
dyslipidemia 80 (72.1%), hypertension 74 (66.7%),
obesity 60 (54.1%), altered blood glucose 49 (44.1%),
and cardiovascular disease 29 (26.1%). We noted
significant increase when using the Chi square test
(p<0.05) in the frequency analysis for dyslipidemia,
hypertension, and cardiovascular disease in patients
between 50 and 60 years of age. No significant
differences were found for gender. The frequency
distribution of some of the pathologies explored like
family antecedents was similar to that of personal
antecedents; these were: hypertension (65.8%), undiffe-
rentiated diabetes (64%), cardiovascular disease
(47.8%), and obesity (41.4%).
Regarding pharmacological antecedents and
according to that reported in literature, we found an
important consumption of medications associated13 to
increased intolerance to glucose; these are: hydrochloro-
thiazide (43.2%) and beta blockers (16.2%). However,
we also found consumption of medications reported as
protectors10 like metformin in 9% of the patients.
From the evaluation of anthropometric measure-
ments, 13.5% presented BMI within normal limits; the
remaining population was overweight or showed some
degree of obesity (Table 3), without notable differences
for gender. It was also found that 86.5% had central
obesity (waist circumference >90 cm in men and >80
cm in women).
Regarding the classification systems that permitted
evaluating the risk for these patients, we considered the
presence of metabolic syndrome according to criteria
from the International Diabetes Federation in 200613,
based on those by the Adult Treatment Panel III (ATPIII),
of which only three could be selected, which were the
ones determined:
1. Prescription of antihypertensive medications in
55.9%
2. Elevated fasting glucose (>100 mg/dl) in 73.9%
3. Waist circumference >90 cm in men and >80 cm in
women: in 82.5% and 88.7%, respectively
Upon applying these criteria, we found 38.7% of
Table 2
Socio-demographic characteristics by gender, socioeconomic level, occupation, and marital status
1. Services: Household, taxi drivers, commerce, sales force    2. Unemployed: Retired or students   3. Industry: Carpenters, welders
4. Administrative: Accountants, aides, assistants, treasurers
     Characteristic Frequency (n=111)     %
Gender
   Men 40 36.0
   Women 71 64.0
Socioeconomic level
   Strata 1 and 2 (Low low – low) 49 44.1
   Stratum 3 (Medium) 55 49.5
   Strata 4 and 5 (Medium high – high) 7 6.3
Occupation
   Services1 75 67.6
   Unemployed 2 15 13.5
   Industry3 10 9.0
   Administrative4 9 8.1
   Construction 2 1.8
Marital status (n=111)
   Lives with a stable partner 86 77.5
Table 3
Distribution of Body Mass Index in the
111 patients, obtained during the interview
Value          Category       Frequency (n=111)    %
18.5-24.9 Normal 15 13.5
25.0-29.9 Overweight 45 40.5
30.0-34.9 Obesity I 39 35.1
35.0-39.9 Obesity II 11 9.9
40 or more Morbid obesity 1 0.9
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metabolic syndrome, still needing the proportion of this
syndrome corresponding to criteria that could not be
determined. There were no significant differences
according to gender.
With the other system that permits evaluating the
risk of cardiovascular disease, DM 2 and hypertension
in the 111 patients, we used the joint analysis of results
of BMI and waist circumference, finding that 35% of
the patients were overweight with central obesity, 45%
with grade I or II obesity and with central obesity, and
1% had morbid obesity and central obesity. The
determination and categorization of this risk can be
seen in Table 4.
Regarding habits, it was found that 66.7% stated not
currently smoking, 26.1% said they were ex smokers,
and 22.5% said they were active consumers of alcohol.
With respect to feeding habits reported by the cases,
we found a daily consumption of simple carbohydrates
at 25%. Regarding whole food integral nutrition, 12%
has a daily consumption which is part of a 37% total
consumption. A total of 19% reported consuming foods
derived from animal fat, as opposed to 43% who reported
intake of foods derived from vegetable fat. Some 66%
stated they never consumed whole foods and 85%
denied consuming low-sugar and low-fat milk.
Regarding physical activity, we found that 53.2% of
the patients were actives and 46.8% sedentary or
insufficiently actives in according to the IPAQ
classification (Table 1).
After evaluating risk perception regarding their pre-
diabetic condition and DM 2, it was found that 71.2%
stated that diabetes and pre-diabetes were different.
Results on other perceptions were: more than 90% of
the patients recognized the harmful effect of consuming
simple carbohydrates, of hyperglycemia, and of being
overweight or obese. Other risk factors acknowledged
were: family antecedents (84.7%), sedentary life style
(80.2%), and dyslipidemia (64.9%). The following
were recognized as DM 2 complications, eye problems
(34.2%), poor scarring (26.1%), cardiovascular disease,
kidney damage, and comatose state (22.5%). The sources
of information recognized by the patients were: health
care personnel (50%), communication media (23.4%),
and third parties (17.1%). When inquiring on the
frequency in conducting glucose control tests, the
patients considered it adequate: once a month (20%),
every three months (10.9%), every six months (38.2%)
and each year (25.5%).
DISCUSSION
The results obtained in the study for some risk
factors coincide with those found in other research
conducted with similar populations14, which could mean
that said factors are more reliable in predicting the risk
of developing DM 2. The mean age of the population
studied ranged between 50 and 60 years, as described in
several conducted in the United States15. In the same
way, significant increase was found in the onset of
dyslipidemia, hypertension, and cardiovascular disease,
Table 4
Risk of cardiovascular disease, DM 2 and hypertension in the 111 patients, according to BMI and waist
circumference obtained during the interview*
BIM (g/m2)              Category                                               Waist circumference
                                                         <90 cm men                     >90 cm men
           <80 cm women (%)                      >80 cm women (%)
18.5-24.9 Normal (13.5)           -          -
25.0-29.9 Overweight (40.5) Increased (5.4) High (35.1)
30.0-34.9 Obesity I (35.1) High Very high (35.1)
35.0-39.9 Obesity II (9.9) Very high Very high (9.9)
40 or more Obesity III (0.9) Extremely high Extremely high (0.9)
* Adapted from the National Institutes of Health (NIH). National Heart, Lung, and Blood Institute (NHLBI). Clinical guidelines on the
identification, evaluation, and treatment of overweight and obesity in adults. US Department of Health and Human Services, Public Health
Service; 1998.
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conditions that have been physio-pathologically
associated 16 with insulin resistance in these patients.
According to the history of the disease, insulin
resistance had to be occurring since earlier, given that
the cut or the study was made when there was alteration
in fasting glucose and glucose tolerance tests. An
aggravating condition in this sense is the identification
of several patients with pre-diabetes between 20 and 30
years of age, agreeing with the tendency currently
reported throughout the world, according to which both
the prevalence to pre-diabetes and DM 2 are increasing
at earlier ages17. Because of this, the American Diabe-
tes Association (ADA) recommends screening patients
below 45 years of age with risk factors associated to
developing DM 218. This is established in Colombia
through the DM 2 care guide from the Ministry of
Social Protection11. However, in spite of the evidence10
of the need to intervene with healthy life styles, in
addition to screening and recommendations to patients
with pre-diabetes, few countries have established
intervention as part of public health programs for these
patients. In Colombia, it is necessary to develop projects
favoring the implementation of these programs.
Similar to that found in other studies15, we found a
man-woman ratio of 1:1.8. We do not know if this could
have anything to do with the fact that household chores
correspond to the most frequent occupation. To elucidate
these findings it would be necessary to implement a
study with greater coverage.
The risk factors identified in this study were: family
antecedents, dyslipidemia, hypertension, obesity,
cardiovascular alterations, sedentary life style, and
inadequate diet, which correspond to that reported in
literature for pre-diabetic patients with risk of developing
DM 219. In this regard, it is important to indicate that
impaired glucose tolerance is considered an independent
risk factor for the development of cardiovascular
disease20.
It has been reported in literature that a BMI above 25
kg/m2 is a prediction factor for DM 219. This study
found that 86.5% of the patients surpassed this BMI
value and, hence, were overweight or obese. Most of
these patients, also had central obesity and a high risk
of metabolic and cardiovascular disease, similar to that
reported in literature20. Nevertheless, it was found that
only 38% of the patients had metabolic syndrome,
according to IDF criteria. It is likely that this study only
reflects a part of all the patients with the syndrome
because only three of its five definition criteria were
determined. When the BMI value and the waist
circumference were used as indicators of metabolic and
cardiovascular risk, as proposed by the WHO, it was
found that 81% of the patients had from high to very
high risk. This can reflect, in turn, the real situation,
given that all the criteria were considered in all the
patients.
The association between obesity and the develop-
ment of cardiovascular and/or metabolic disease has
been explained in literature through the mechanisms
implied in the genesis of these pathologies. It is suggested
that in obesity there is micro-vascular impairement that
leads to endothelial dysfunction, which increases
peripheral vascular resistance, and consequently blood
pressure, as well as diminishing the peripheral
consumption of glucose leading to insulin resistance
and hypertension. With regard to the above has been
proposed, that the blockage of mechanisms implied in
micro-vascular alterations could impede the develop-
ment of associated chronic disease, among them DM
216.
The information about the diet only refers to the
frequency of food intake, without considering the
number of portions consumed or the time transpired
since its instauration. The daily or weekly consumption
referred to by the patients of the nutritional groups
affecting body weight (carbohydrates and fats) was
low, and although that of simple carbohydrates should
be null; these finding did not correspond to the BMI
evaluation. Also, the intake of protector nutrition21 like
whole foods or low-fat milk was still very restricted,
which could be due to their high costs and to the fact that
said diet is not part of the gastronomic customs in our
region. With the results obtained, we could surmise that
there is no real perception of the diet and that greater
clarity is needed on the importance of the protector
foods.
Regarding physical activity, we found similar
proportions of activity and inactivity. What has been
found in literature is that weight changes are observed
after six months and glycemia changes are observed
after one year of continuous diet and physical activity
intervention, where 700 kilocalories are consumed
after 2.5 h per week of physical activity10. The
information obtained was very subjective, given that it
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was from the perception of the patient in terms of the
time and intensity of the physical activity during the
seven days prior to the day of the survey. The information
was empirical because the description of the activities
did not report if they were attending intervention
programs and much less in their pre-diabetic condition,
mainly because in our health care entities this type of
preventive intervention still does not exist as it does in
other countries22.
Upon inquiring about awareness of the frequency at
which glycemia control tests should be conducted, it
was found that most of the population knew that such
control should be carried out every six and/or 12 months,
which corresponded with the frequencies they reported
for taking the test.
The patients included in this study had both altered
tests (fasting glucose and glucose tolerance test), i.e.,
they were at a moment of the history of the disease that
was very close to DM 2. However, although they
recognized the risk of developing DM 2, 64% of the
patients had no clear idea of being close to developing
it.
CONCLUSIONS
According to criteria from the WHO, 81% of the
patients had high cardio-metabolic risk. In over half the
cases, pathological antecedents were found clearly
related with the state of insulin resistance like
dyslipidemia, hypertension, and obesity, which were
also present as family antecedents. An aggravating
factor for this situation is that the medical recommen-
dations received from the health care service are not
sufficient, given that the conduct they have regarding
physical activity and nutrition was not adequate to
control excess weight and altered fasting glycemia. On
the other hand, according to the perception reported by
patients regarding DM 2, most patients recognize the
risk factors for developing it, but few perceive the
complications that such disease can bring for their
health.
A high percentage of the pre-diabetic individuals
had not been diagnosed for disorder of carbohydrate
metabolism, for which a model is required for early
identification and detection, like that developed in this
study, which permits an appropriate promotion and
prevention of these patients.
Finally, new studies are necessary in a Latin
American population with bigger samples, including
individuals belonging to public and private health care
systems, in whom we can also study other variables of
cardio-metabolic risk like lipid profile, glycated
hemoglobin, and c-reactive protein, which permit
recognizing differences with other widely studied
populations and design more specific strategies, which
are cost effective and viable in Latin America to prevent
the development of DM 2 with adequate intervention in
healthy life style habits.
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